Dehydroepiandrosterone (DHEA) is considered to increase the chances of pregnancy in women with decreased ovarian reserve (DOR), and is frequently used in nearly over a third of IVF centers worldwide. Adding credence to the currently available level II and III evidences, a comprehensive review and meta-analysis has reported that DHEA supplementation improves pregnancy chances in women with DOR. Continue Reading

A new breakthrough blood test that helps predict the approximate age at which a woman would attain menopause has been developed. The preliminary findings of this population-based cohort study were presented at the 26th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) held at Rome from 27^th to 30^th June 2010. The researchers are hopeful that the test could help women determine the age at which they reach menopause and accordingly plan their motherhood. Continue Reading